Sanofi-Pasteur Gets $100 Mil. HHS Contract to Make Avian Influenza Vaccine
This article was originally published in The Pink Sheet Daily
Executive Summary
The number of viable doses will depend upon the outcome of ongoing dosing studies, HHS says.
You may also be interested in...
Sanofi-Pasteur H5N1 Avian Flu Vaccine Stimulates Immune Response In Trial
The 300-subject study showed that a regimen of two 30 mcg doses with adjuvant was safe and well tolerated.
Sanofi-Pasteur H5N1 Avian Flu Vaccine Stimulates Immune Response In Trial
The 300-subject study showed that a regimen of two 30 mcg doses with adjuvant was safe and well tolerated.
Roche Will Sell Tamiflu Under Tiered Pricing System For Pandemic Use
The firm names Shanghai Pharmaceutical Group as the first sub-licensee of the antiviral oseltamivir.